Supplementary Material for: Trichological Disorders in Organ Transplant Recipients - Case Report and Literature Review
May 2026
in “
Figshare
”
Studysummary This case report highlights hair loss as a side effect of tacrolimus-based immunosuppression in a kidney transplant patient, improving after switching to cyclosporine A. The authors emphasize the importance of monitoring and managing such side effects to ensure treatment adherence and patient well-being.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This document discusses a case of a 31-year-old kidney transplant recipient who developed significant alopecia due to tacrolimus-based immunosuppression. The hair loss had a psychological impact, leading the patient to consider stopping treatment. Dermatological evaluation showed androgenetic alopecia and telogen effluvium. Switching from tacrolimus to cyclosporine A improved hair regrowth and well-being. A literature review found four similar cases linking alopecia to immunosuppressive therapy in organ transplant recipients. The study emphasizes the importance of awareness of hair disorders in transplant patients, suggesting regular dermatological assessments and potential adjustments in immunosuppressive regimens to improve patient quality of life and treatment adherence.
